Anna Silvia Pistocchi earned her degree in Biology from the University of Milan in 2003 and her PhD in Molecular and Cellular Biology from the same institution in 2006. She is an Associate Professor of Applied Biology at the Department of Medical Biotechnology and Translational Medicine at the University of Milan. Her main research interests are linked to elucidating the molecular mechanisms that lead to the proper differentiation of the vertebrate muscular system, using zebrafish as a model with connections to human diseases. Her primary objective for FFC Ricerca is to confirm the effectiveness of phage therapy against Pseudomonas aeruginosa infections in vivo, using zebrafish as an animal model for cystic fibrosis.
Projects funded by FFC Ricerca as Principal Investigator
FFC#12/2022
Evaluation of phage interactions with host immune system in models of cystic fibrosis: one step toward phage therapy application
FFC#23/2019
Potential action of phages as immunomodulators in cystic fibrosis
FFC#22/2017
In vivo validation of phage therapy against Pseudomonas aeruginosa infections using the new Zebrafish (Danio rerio) animal model
Publications from FFC Research projects
- Cafora M, Deflorian G, Forti F, et al., Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model. Sci Rep. 2019 Feb 6;9(1):1527. doi: 10.1038/s41598-018-37636-x.
- Marco Cafora, Gianluca Deflorian, Francesca Forti, et al. Phage Therapy Against Pseudomonas Aeruginosa Infections in a Cystic Fibrosis Zebrafish Model. Sci Rep, 9 (1), 1527 2019 Feb 6
- Marco Cafora, Gianluca Deflorian, Francesca Forti, Laura Ferrari, Giorgio Binelli, Federica Briani, Daniela Ghisotti, Anna S Pistocchi. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model. The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis. Multidisciplinary Respiratory Medicine, 2019, 14 (Suppl 1):5